4 结果
FIELD OF THE INVENTION
The present invention relates to the Janus kinase (JAK) inhibitors 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octanenitrile or 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]heptanenitrile, as well as its compositions and methods of use, which is useful in
FIELD OF THE INVENTION
The present invention relates to the Janus kinase (JAK) inhibitors 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octanenitrile or 3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]heptanenitrile, as well as its compositions and methods of use, which is useful in
BACKGROUND OF THE INVENTION
The present invention relates to new rigid chelating structures, methods for preparing the structures and their use in preparing radioimmunoconjugates for SPECT and PET imaging and for radiotherapy.
The use of radiometals to label proteins and antibodies provides a
BACKGROUND OF THE INVENTION
The present invention relates to new rigid chelating structures, methods for preparing the structures and their use in preparing radioimmunoconjugates for SPECT and PET imaging and for radiotherapy.
The use of radiometals to label proteins and antibodies provides a